US FDA panel okays COVID-19 booster jabs for people over 65
Recommendation comes after science advisory panel rejects Pfizer proposal to provide booster jabs to most people.Recommendation comes after science advisory panel rejects Pfizer proposal to provide booster jabs to most people.